Evidence map›Paper›PMID 33921428›Full record

ArticleInternational journal of molecular sciences2021

Metabolic Shifts as the Hallmark of Most Common Diseases: The Quest for the Underlying Unity.

Laurent Schwartz, Marc Henry, Khalid O Alfarouk, Stephan J Reshkin, Miroslav Radman

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laurent SchwartzAssistance Publique des Hôpitaux de Paris, 75004 Paris, France.
Marc HenryLaboratoire de Chimie Moléculaire de l'Etat Solide, UMR 7140 UDS-CNRS, University of Strasbourg, 4 rue Blaise Pascal, F-67000 Strasbourg, France.
Khalid O AlfaroukDepartment of Pharmacology, College of Pharmacy, Zamzam University College, Khartoum 11123, Sudan.ORCID 0000-0001-8656-6117
Stephan J ReshkinDepartment of Bioscience, Biotechnology and Biopharmaceutics, University of Bari, 70126 Bari, Italy.ORCID 0000-0001-9757-5908
Miroslav RadmanMediterranean Institute for Life Sciences (MedILS), 21000 Split, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A hyper-specialization characterizes modern medicine with the consequence of classifying the various diseases of the body into unrelated categories. Such a broad diversification of medicine goes in the opposite direction of physics, which eagerly looks for unification. We argue that unification should also apply to medicine. In accordance with the second principle of thermodynamics, the cell must release its entropy either in the form of heat (catabolism) or biomass (anabolism). There is a decreased flow of entropy outside the body due to an age-related reduction in mitochondrial entropy yield resulting in increased release of entropy in the form of biomass. This shift toward anabolism has been known in oncology as Warburg-effect. The shift toward anabolism has been reported in most diseases. This quest for a single framework is reinforced by the fact that inflammation (also called the immune response) is involved in nearly every disease. This strongly suggests that despite their apparent disparity, there is an underlying unity in the diseases. This also offers guidelines for the repurposing of old drugs.

Indexed as

Drug RepositioningEntropyGuidelines as TopicHumansImmunityMedicineMetabolismSpecializationAlzheimera paradigm shiftcancerentropylactic acidmethylene bluemitochondriapHipsychiatry

Identifiers

PMID33921428
PMCPMC8068795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.